Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation crawled date : 2022 - 10 - 26 save search
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
Published: 2022-10-26 (Crawled : 19:00) - globenewswire.com
RAIN | $1.21 0.0% 3.7M
|
Manufacturing
|
| O: 5.5%
H: 5.04%
C: -2.52%
symposium therapeutics presentation
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
Published: 2022-10-26 (Crawled : 18:00) - globenewswire.com
GRTX | $0.199 17.06% 14.57% 18M
|
Health Technology
|
| O: -1.69%
H: 5.71%
C: -4.0%
meeting presentation
Aldeyra Therapeutics Announces Oral Presentation of Phase 3 Data at the American Academy of Optometry 2022 Annual Meeting
Published: 2022-10-26 (Crawled : 13:20) - biospace.com/
ALDX 4 | $3.98 2.84% 2.76% 640K
|
Health Technology
|
| O: 0.0%
H: 8.0%
C: 7.81%
meeting therapeutics presentation
Equillium Announces Presentation of Data Demonstrating Biological Importance of Multi-Cytokine Inhibitors EQ101 and EQ102 at the La Jolla Immunology Conference
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
EQ | $1.85 0.0% 93K
|
Health Technology
|
| O: 0.0%
H: 1.81%
C: 0.0%
eq101 conference immunology presentation
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
Published: 2022-10-26 (Crawled : 12:00) - biospace.com/
ATHE | News | $1.98 -3.42% -3.54% 120K
|
Health Technology
|
| O: 1.64%
H: 2.2%
C: -4.42%
meeting neurological therapeutics presentation study
TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the 2022 European Committee for Treatment and Research in Multiple Sclerosis
Published: 2022-10-26 (Crawled : 12:00) - globenewswire.com
TGTX | $13.825 -1.25% -1.27% 3.1M
|
Health Technology
|
| O: -0.93%
H: 11.07%
C: 3.75%
treatment trials research therapeutics presentation sclerosis multiple sclerosis
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
Published: 2022-10-25 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | News | $1.98 -3.42% -3.54% 120K
|
Health Technology
|
| O: 1.64%
H: 2.2%
C: -4.42%
meeting neurological therapeutics presentation study
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.